abstract |
An alpha 2B receptor agonist for use in a method of treating dry eye disease, wherein the alpha 2 agonist is selected from the group consisting of: i) an imidazoline, wherein said imidazoline is a compound of the formula ** Formula ** or a pharmaceutically acceptable salt thereof; and ii) an imidazole, wherein imidazole is a compound selected from the group consisting of: ** Formula ** |